Overall Technical outlook

Price Summary

2026-04-30, saw CONCORDBIO's stock open at 1140.0, hit a peak of 1154.2, fall to a low of 1119.5, and close higher 0.18% at 1142.0, with 298729 shares changing hands.
The highest price the stock achieved in the past 52 weeks is 2130.4, while the lowest price it saw is 1014.8.
5 analysts estimate that the future price of CONCORDBIO will fall between 1170.0 and 1400.0, with an average price expectation of approximately 1319.0.

Technicals

Support and Resistance: The current price of 1142.0 is supported at 1109.0, with resistance at 1340.8. This suggests that the price for CONCORDBIO might remain between these levels, where 1109.0 acts as a floor and 1340.8 as a ceiling in the market.
CONCORDBIO supportResistance 65e237
Support/Resistance for CONCORDBIO


Aroon: The AROON is currently in a neutral position for Concord Biotech Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
CONCORDBIO aroon 65e237
Aroon chart for Concord Biotech Limited


Bol. Bands: The current price is above the upper Bollinger Band, maintaining this position since its recent surge. This could indicate strong bullish momentum, potentially suggesting that the asset is overbought. While traders may see this as a sign of continued strength, they should also be cautious of a potential correction, as extended periods above the band often lead to reversals.
CONCORDBIO bbands 65e237
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, setting a crucial support level. This strong support could bolster the ongoing upward trend, suggesting that the market may remain in a positive trajectory. Investors may view this as a sign of sustained bullish momentum.
CONCORDBIO psar 65e237
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The STOCHASTIC is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
CONCORDBIO stoch 65e237
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
CONCORDBIO trippleSMA 65e237
Tripple SMA chart for Concord Biotech Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.